Provider of medical and health care products for all segments of health care market including hospitals and clinics, nur
Provider of medical and health care products for all segments of health care market including hospitals and clinics, nursing homes and long-term care facilities, private medical practices, therapists, dental clinics and more.
Medical Supplies📍 Beijing, ChinaFounded 2015
Current Valuation
$650M
as of 2019-Q2
PRIVATE
QL Price
$650M
0% vs last round
QuantLogix's current estimate for LyncMed, published 2026-09-27 — in line with the last disclosed round of $650M (2019-Q2).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$650M
2019-Q2
weight 0.01
How this price has held up
No round has priced for LyncMed since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, LyncMed, 2026-09-27 (ca9cd68e6688fb6b).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is LyncMed going public?
No. LyncMed is private and has not filed to go public. There is no S-1 on file.
What is LyncMed's valuation in 2026?
LyncMed is valued at $650M as of 2019-Q2, set by its Series B1 ($20M, May 2019). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has LyncMed filed an S-1?
No public S-1 is on file for LyncMed.
How much has LyncMed raised?
LyncMed has raised $45.68M in total, most recently a Series B1 of $20M in May 2019.
Is LyncMed publicly traded — can you buy LyncMed stock?
No. LyncMed is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for LyncMed on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2015
HQ
Beijing, China
Employees
66
Total Raised
$45.68M
Last Round
Series B1 — $20M (May 2019)
IPO Status
private
Fundraising Status
Series B1 · $20M · 7y 4mo ago
privateTotal raised $45.68M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B1
$20M
May 2019
—
$650M
Talent Signal
No public careers page or job board could be found for LyncMed as of 2026-09-16. That itself is a datapoint: no open external hiring surface.
Checked the company site and major hosted job boards. Re-checked monthly.
Service IndustryE-CommerceMedical DeviceManufacturing
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2019-Q2. Refreshed quarterly.